Schreiner MediPharm joins tracking standardization consortium

Schreiner MediPharm, a German specialty label developer, has joined DoseID, the US-based industry association launched in August that works to standardize the use of RFID tags in healthcare. The company is focused closely on this technology—in fact, it augmented its Cap-Lock tamper-evident specialty label with an RFID inlay in October.

DoseID’s goal is to monitor the performance of RFID-tagged drug products as they move through the pharma supply chain. The products are tracked across all hardware and software systems—from the manufacturer, through the distributor, to the hospital and ultimately, the patient.

Pharmaceuticals can be tracked by serializing medications, containers and devices, but the RFID tags need perform well in hospital and healthcare IT systems—otherwise, the products won’t be able to be tracked from start to finish.

The unit level serialization supported by DoseID exceeds the requirements set forth by the Drug Supply Chain Security Act (DSCSA). To ensure adherence to the standards established by the consortium and conformity with the requirements of pharmaceutical manufacturers, compounding pharmacies, pharmacy automation services providers and manufacturers of RFID inlays and tags, a special RFID tag certification also is awarded after third-party testing.